News & Analysis on Clinical Trial Services & Contract Research And Development
You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article to learn the four warning signs you should keep an eye out for, as they often spell operational and financial disaster.
On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants from underrepresented racial and ethnic populations, specifically Black or African American,...
For more product information visit Elligo Health Research®.